Find clinical trials for Melanoma in New Haven, CT
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Melanoma trials near New Haven, CT, USA:
This is an open label study evaluating lifileucel (LN-144) in patients with metastatic uveal melanoma....
Phase 1
Harrison, New York, United States and 1 other location
ipilimumab is a safe and effective treatment that causes few or mild side effects for locally advanced or metastatic, unresectable, refractory melanoma...
Phase 2
Commack, New York, United States and 9 other locations
The study is focused on patients with a type of skin cancer known as melanoma. The aim of the study is to see how safe and effective the com...
Phase 3
New Haven, Connecticut, United States and 55 other locations
participants with a type of skin cancer known as melanoma.The objective of this study is to see if the combination of fianlimab and cemipli...
Phase 2, Phase 3
Hartford, Connecticut, United States and 24 other locations
and safe treatment for people with advanced or metastatic mucosal melanoma that has not been treated before.The researchers think that a com...
Phase 2
Harrison, New York, United States and 1 other location
is to test the effects of the study drug, ensartinib, on the patient and the cancer. Ensartinib is a new, investigational type of treatment for melanoma...
Phase 2
Harrison, New York, United States and 3 other locations
and pharmacokinetic profiles of botensilimab as monotherapy and in combination with balstilimab in participants with advanced cutaneous melanoma...
Phase 2
New Haven, Connecticut, United States and 50 other locations
with the standard-of-care drug combination, nivolumab and relatlimab, is a safe and effective treatment for people with untreated, unresectable melanoma...
Phase 2
Hartford, Connecticut, United States and 8 other locations
Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma
This is a phase 2, Simon's 2-stage designed study with 2 cohorts of anti-PD-1/PD-L1 experienced patients with untreated brain metastases: 1) melanoma...
Phase 2
New Haven, Connecticut, United States
study to evaluate the efficacy, safety, and tolerability of APX005M in combination with nivolumab and ipilimumab in patients with advanced melanoma...
Phase 1
New Haven, Connecticut, United States and 1 other location
Clinical trials
Research sites
Resources
Legal